Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, and the California NanoSystems Institute at UCLA today announced a partnership designed to collaborate on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback